Qiao D, Jin J, Xing J, Zhang Y, Jia N, Ren X, et al. Baicalein inhibits gastric cancer cell proliferation and migration through a FAK interaction via AKT/mTOR signaling. Am J Chin Med. 2021;49:525–41.
Article CAS PubMed Google Scholar
Xu L, Zaky MY, Yousuf W, Ullah A, Abdelbaset GR, Zhang Y, et al. The anticancer potential of apigenin via immunoregulation. Curr Pharm Des. 2021;27:479–89.
Article CAS PubMed Google Scholar
Elham A, Arken M, Kalimanjan G, Arkin A, Iminjan M. A review of the phytochemical, pharmacological, pharmacokinetic, and toxicological evaluation of quercus infectoria galls. J Ethnopharmacol. 2021;273:113592.
Article CAS PubMed Google Scholar
Cragg GM, Newman DJ. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta. 2013;1830:3670–95.
Article CAS PubMed PubMed Central Google Scholar
Zhang J, Gao J, Cui J, Wang Y, Jin Y, Zhang D, et al. Tumor-associated macrophages in tumor progression and the role of traditional Chinese medicine in regulating TAMs to enhance antitumor effects. Front Immunol. 2022;13:1026898.
Article CAS PubMed PubMed Central Google Scholar
Zhao L, Zhao H, Zhao Y, Sui M, Liu J, Li P, et al. Role of ginseng, quercetin, and tea in enhancing chemotherapeutic efficacy of colorectal cancer. Front Med. 2022;9:939424.
Harborne JB, Williams CA. Advances in flavonoid research since 1992. Phytochemistry. 2000;55:481–504.
Article CAS PubMed Google Scholar
Ulusoy HG, Sanlier N. A minireview of quercetin: from its metabolism to possible mechanisms of its biological activities. Crit Rev Food Sci Nutr. 2020;60:3290–303.
Article CAS PubMed Google Scholar
Qian L, Xu H, Yuan R, Yun W, Ma Y. Formononetin ameliorates isoproterenol induced cardiac fibrosis through improving mitochondrial dysfunction. Biomed Pharmacother. 2024;170:116000.
Article CAS PubMed Google Scholar
Yang K, Zeng L, Ge A, Yi Y, Wang S, Ge J. Exploring the oxidative stress mechanism of Buyang Huanwu decoction in intervention of vascular dementia based on systems biology strategy. Oxid Med Cell Longev. 2021;2021:8879060.
Article PubMed PubMed Central Google Scholar
Xiang K, Shen P, Gao Z, Liu Z, Hu X, Liu B, et al. Formononetin protects LPS-induced mastitis through suppressing inflammation and enhancing blood-milk barrier integrity via AhR-induced Src inactivation. Front Immunol. 2022;13:814319.
Article CAS PubMed PubMed Central Google Scholar
Kim C, Lee SG, Yang WM, Arfuso F, Um JY, Kumar AP, et al. Formononetin-induced oxidative stress abrogates the activation of STAT3/5 signaling axis and suppresses the tumor growth in multiple myeloma preclinical model. Cancer Lett. 2018;431:123–41.
Article CAS PubMed Google Scholar
Ren J, Xu HJ, Cheng H, Xin WQ, Chen X, Hu K. Synthesis and antitumor activity of formononetin nitrogen mustard derivatives. Eur J Med Chem. 2012;54:175–87.
Article CAS PubMed Google Scholar
Fu DJ, Zhang L, Song J, Mao RW, Zhao RH, Liu YC, et al. Design and synthesis of formononetin-dithiocarbamate hybrids that inhibit growth and migration of PC-3 cells via MAPK/Wnt signaling pathways. Eur J Med Chem. 2017;127:87–99.
Article CAS PubMed Google Scholar
Venugopala KN, Habeebuddin M, Aldhubiab BE, Asif AH. Design, synthesis, and in vitro evaluation of novel indolyl dihydropyrazole derivatives as potential anticancer agents. Molecules. 2021;26:5235.
Article CAS PubMed PubMed Central Google Scholar
ElBordiny HS, El-Miligy MM, Kassab SE, Daabees H, Ali WA, El-Hawash SA. Design, synthesis, biological evaluation and docking studies of new 3-(4, 5-dihydro-1H-pyrazol/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors. Eur J Med Chem. 2018;145:594–605.
Article CAS PubMed Google Scholar
Kaproń B, Łuszczki JJ, Płazińska A, Siwek A, Karcz T, Gryboś A, et al. Development of the 1,2,4-triazole-based anticonvulsant drug candidates acting on the voltage-gated sodium channels. Insights from in-vivo, in-vitro, and in-silico studies. Eur J Pharm Sci. 2019;129:42–57.
Emami L, Sadeghian S, Mojaddami A, Khabnadideh S, Sakhteman A, Sadeghpour H, et al. Design, synthesis and evaluation of novel 1,2,4-triazole derivatives as promising anticancer agents. BMC Chem. 2022;16:91.
Article CAS PubMed PubMed Central Google Scholar
Edlund C, Oh H, Nord CE. In vitro activity of linezolid and eperezolid against anaerobic bacteria. Clin Microbiol Infect. 1999;5:51–3.
Article CAS PubMed Google Scholar
Fasciolo G, Nicolini A, Vacca N, Viglierchio P. Efficacy and safety of moguisteine in comparison with levodropropizine in patients with cough associated with chronic obstructive pulmonary disease, lung cancer, or pulmonary fibrosis. Curr Ther Res Clin Exp. 1994;55:251–61.
Alam MM. 1,2,3‐triazole hybrids as anticancer agents: a review. Arch Pharm. 2022;355:2100158.
Deng C, Yan H, Wang J, Liu K, Liu BS, Shi YM. 1, 2, 3-triazole-containing hybrids with potential antibacterial activity against ESKAPE pathogens. Eur J Med Chem. 2022;244:114888.
Article CAS PubMed Google Scholar
Feng LS, Zheng MJ, Zhao F, Liu D. 1,2,3‐triazole hybrids with anti‐HIV‐1 activity. Arch Pharm. 2021;354:2000163.
Zhou S, Hou X, Li L, Guo L, Wang H, Mao L, et al. Discovery of dolutegravir-1, 2, 3-triazole derivatives against prostate cancer via inducing DNA damage. Bioorg Chem. 2023;141:106926.
Article CAS PubMed Google Scholar
Hrimla M, Bahsis L, Laamari MR, Julve M, Stiriba SE. An overview on the performance of 1, 2, 3-triazole derivatives as corrosion inhibitors for metal surfaces. Int J Mol Sci. 2021;23:16.
Article PubMed PubMed Central Google Scholar
Bonandi E, Christodoulou MS, Fumagalli G, Perdicchia D, Rastelli G, Passarella D. The 1, 2, 3-triazole ring as a bioisostere in medicinal chemistry. Drug Discov Today. 2017;22:1572–81.
Article CAS PubMed Google Scholar
Hoffman GR, Schoffstall AM. Syntheses and applications of 1, 2, 3-triazole-fused pyrazines and pyridazines. Molecules. 2022;27:4681.
Article CAS PubMed PubMed Central Google Scholar
Fu DJ, Zhang SY, Liu YC, Yue XX, Liu JJ, Song J, et al. Design, synthesis and antiproliferative activity studies of 1, 2, 3-triazole–chalcones. MedChemComm. 2016;7:1664–71.
Comments (0)